• Return to Headlines

ABIOMED Shares Up 41.9% Since SmarTrend's Buy Recommendation (ABMD)

By Shiri Gupta

SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 5 months, ABIOMED has returned 41.87% as of today's recent price of $119.60.

ABIOMED share prices have moved between a 52-week high of $122.98 and a 52-week low of $59.04 and are now trading 103% above that low price at $119.60 per share. The 200-day and 50-day moving averages have moved 0.56% higher and 1.34% higher over the past week, respectively.

Abiomed, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. It sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. The company was founded in 1981 and is based in Danvers, Massachusetts.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of ABIOMED shares.

Log in and add ABIOMED (ABMD) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights abiomed

Ticker(s): ABMD